Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.22.1
Stockholders’ Equity (Tables)
 9 Months Ended
Apr. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of amounts of share-based compensation expense
    Three months ended
April 30,		     Nine months ended
April 30,		  
    2022     2021     2022     2021  
Stock options   $ 181     $ 297     $ 841     $ 638  
Performance stock units     (105 )    
—
       57      
—
  
Restricted stock units     86      
—
       159       2  
    $ 162     $ 297     $ 1,057     $ 640  

 
Schedule of share-based payment arrangement
    Three months ended
April 30,		     Nine months ended
April 30,		  
    2022     2021     2022     2021  
Selling, general and administrative   $ 158     $ 258     $ 1,037     $ 574  
Cost of revenues     4       39       20       66  
    $ 162     $ 297     $ 1,057     $ 640  

 
Schedule of stock option activity
    Options       Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term		     Aggregate
Intrinsic
Value (000s)		  
Outstanding at July 31, 2021       2,504,563     $ 3.74                  
Awarded     1,100,750     $ 3.32                  
Exercised     (11,300 )      2.49             $    
Cancelled or expired     (406,396 )   $ 7.05                  
Outstanding at end of period     3,187,617     $ 3.18       2.4 years       $ 179  
Exercisable at end of period     1,794,399     $         0.9 years       $ 139   

 
Schedule of summarizes PSU’s granted and outstanding
Grant Date   Performance
period
end date		   Total Grant     Forfeitures     Outstanding     Fair
Market
Value
At Grant
Date (000s)		  
10/15/2019   7/31/2022     80,500       (14,500 )     66,000     $ 222  
10/19/2020   7/31/2023     98,600      
—
       98,600     $ 207  

 
Schedule of summarizes RSU activity
    Number of RSUs
outstanding 		    Weighted
Average Fair
Value per Unit at
Date of Grant
or Vesting		     Weighted
Average
Remaining
Contractual  
Term		     Aggregate
Intrinsic
Value (000s)		  
Granted     377,189     $ 3.13                  
Vested    
—
      
—
                  
Cancelled    
—
     $
—
                  
Outstanding at end of period     377,189     $ 3.18       2.36 years       $ 1,181  
Expected to vest at end of period     377,189        $           2.36 years         $ 1,181